Dr. Au Yeung Kwok Him Rex - Pathology
Specialist in Pathology
Highlights
- MCHK RegisteredVerified
- Specialist in PathologyBachelor of Medicine and Bachelor of Surgery (MBBS) · The Hong Kong College of Pathologists · Medical degree 2009
- InsuranceBeing compiled｜See details
About
Dr. Au Yeung Kwok Him Rex is a registered Pathology specialist in Hong Kong.
Education
Specialist in Pathology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)2009
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Au Yeung Kwok Him Rex? Claim page and update insurance →
FAQ
Is Dr. Au Yeung Kwok Him Rex any good?
Dr. Au Yeung Kwok Him Rex is a registered Pathology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Au Yeung Kwok Him Rex do?
Dr. Au Yeung Kwok Him Rex practises in Pathology.
Are you Dr. Au Yeung Kwok Him Rex? Claim this page to update and manage.
ClaimResearch and publications
40 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular Insights.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2025
- SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids.Scientific reports · 2024
- Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphoma.Leukemia · 2024
- Mycolyltransferase is important for biofilm formation and pathogenesis of <i>Tsukamurella</i> keratitis.Emerging microbes & infections · 2024
- Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma.Leukemia · 2023
- Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.Haematologica · 2022
- Epigenetic Silencing of Tumor Suppressor lncRNA <i>NKILA</i>: Implication on NF-κB Signaling in Non-Hodgkin's Lymphoma.Genes · 2022
- Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease.Annals of hematology · 2022
- Clonal heterogeneity of polymorphic B-cell lymphoproliferative disease, EBV-positive, iatrogenic/immune senescence: implications on pathogenesis and treatment.Hematology (Amsterdam, Netherlands) · 2022
- Epstein-Barr virus-positive diffuse large B-cell lymphoma after frontline brentuximab vedotin treatment of classical Hodgkin lymphoma.Annals of hematology · 2022
- CD3+CD4+ lymphoid neoplasm: diagnostic clues for plasmablastic lymphoma instead of peripheral T-cell lymphoma.Annals of hematology · 2022
- Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity.Science advances · 2021
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer